Romas Kudirka

Title: Romas Kudirka: Innovator in Immunoconjugate Technology

Introduction

Romas Kudirka is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of immunoconjugates, particularly through his innovative work at Bolt Biotherapeutics, Inc. His research focuses on the development of novel therapeutic agents for cancer treatment.

Latest Patents

Romas Kudirka holds a patent for "Thienoazepine immunoconjugates, and uses thereof." This invention provides immunoconjugates of Formula I, which comprise an antibody linked by conjugation to one or more thienoazepine derivatives. The patent also details thienoazepine derivative intermediate compositions that include a reactive functional group. These intermediate compositions serve as suitable substrates for the formation of immunoconjugates through a linker or linking moiety. Furthermore, the invention outlines methods for treating cancer using these immunoconjugates.

Career Highlights

Throughout his career, Romas has demonstrated a commitment to advancing cancer treatment through innovative technologies. His work at Bolt Biotherapeutics, Inc. has positioned him as a key player in the development of cutting-edge immunotherapeutic solutions.

Collaborations

Romas collaborates with Brian Salvatore Safina, contributing to the collective expertise and innovation within their field.

Conclusion

Romas Kudirka's contributions to immunoconjugate technology exemplify the impact of innovative thinking in the fight against cancer. His patent and ongoing work at Bolt Biotherapeutics, Inc. highlight the importance of research and collaboration in developing effective treatments.